MSI of CDH2 gene was not statistically significantly associated with a particular grade, but it occurred at relatively similar frequencies across all stages of malignancy contributing to genome instability already in the early stages of intracranial meningioma development. This evidence concerns the gene CDH2 and intracranial meningioma.